Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Carasent AB (publ) (E0C.F)

2.1800
-0.0200
(-0.91%)
As of 10:08:15 AM GMT+2. Market Open.
Loading Chart for E0C.F
  • Previous Close 2.2000
  • Open 2.1800
  • Bid 2.2000 x --
  • Ask 2.2100 x --
  • Day's Range 2.1800 - 2.1800
  • 52 Week Range 1.5350 - 2.2000
  • Volume 600
  • Avg. Volume 9
  • Market Cap (intraday) 157.668M
  • Beta (5Y Monthly) -0.99
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Apr 11, 2025
  • Forward Dividend & Yield 0.16 (10.69%)
  • Ex-Dividend Date Nov 15, 2023
  • 1y Target Est --

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webdoc X, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. Carasent AB (publ) was founded in 1997 and is headquartered in Gothenburg, Sweden.

carasent.com

199

Full Time Employees

December 31

Fiscal Year Ends

Recent News: E0C.F

View More

Performance Overview: E0C.F

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

E0C.F
15.34%
OMX Stockholm 30 Index (^OMX)
2.71%

1-Year Return

E0C.F
42.02%
OMX Stockholm 30 Index (^OMX)
5.50%

3-Year Return

E0C.F
42.02%
OMX Stockholm 30 Index (^OMX)
17.34%

5-Year Return

E0C.F
42.02%
OMX Stockholm 30 Index (^OMX)
53.10%

Compare To: E0C.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: E0C.F

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    156.78M

  • Enterprise Value

    137.16M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.94

  • Price/Book (mrq)

    1.98

  • Enterprise Value/Revenue

    5.11

  • Enterprise Value/EBITDA

    59.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.85%

  • Return on Assets (ttm)

    -2.07%

  • Return on Equity (ttm)

    -3.82%

  • Revenue (ttm)

    294.35M

  • Net Income Avi to Common (ttm)

    -34.9M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    253.21M

  • Total Debt/Equity (mrq)

    4.34%

  • Levered Free Cash Flow (ttm)

    12.46M

Research Analysis: E0C.F

View More

Company Insights: E0C.F

Research Reports: E0C.F

View More